In [Fig 5](#pone.0174048.g001){ref-type="fig"}, the graphs of [Fig 5C](#pone.0174048.g001){ref-type="fig"} lack percentages for individual recipients of effector T cell subsets. Please see the updated [Fig 5](#pone.0174048.g001){ref-type="fig"} here.

![Bcl6 controls generation of GC Tfh, but not cytokine profile, in responding effector cells.\
(A) Naïve (CD44^lo^CD25^-^) CD4 T cells (2x10^6^) from either Bcl6^fl/fl^ CD4^Cre^ (Bcl6 cKO) or Bcl6^fl/fl^ (WT) were labeled with cell trace violet (CTV) and adoptively transferred into Ly5.1 (CD45.1) congenic mice, followed by *P*. *chabaudi* infection. On day 7 post-infection, splenocytes were harvested and stained with (B) CD4, CD45.2, CTV, (C, D) PD-1, CXCR5, (E) IFN-γ, IL-21, and (F) IFN-γ, IL-10. (B) Plots showing the gating on responding CD4^+^ CD45.2^+^ CTV^-^ T cells. (C) Graph shows percentages for individual recipients of effector T cell subsets. No CD45.2^+^ CXCR5^hi^PD-1^hi^ GC Tfh cells were detected in any recipient of Bcl6 cKO T cells. (D) Bar graph shows CXCR5 MFI of CD4^+^ CD45.2^+^ CTV^-^ donor cells. (E) Plots and bar graph of average IFN-γ and IL-21 cytokine producers in the responding donor cells (CD45.2^+^ CTV^-^) in recipients of WT and Bcl6 cKO T cells. (F) Dot plot showing intracellular cytokine staining. Data are representative of three independent experiments with 4--5 animals per group. Numbers within plots represent mean percentages. Statistical significance was obtained using Students *t*-test. Error bars represent the SEM; \*p \< 0.05, \*\*\*p \< 0.001, ns = not significant.](pone.0174048.g001){#pone.0174048.g001}
